MLchartDataset catalogue

sequential AC/Taxol-Trastuzumab regimen

Term · Oncology and biomedicine · MLC-T-ONC-007675

An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen, and AC-TH regimen.

Table 1. Record
IdentifierMLC-T-ONC-007675
FieldOncology and biomedicine
SynonymsAC-T-T; AC-T-T regimen; AC-TH regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007675",
  "term": "sequential AC/Taxol-Trastuzumab regimen",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen, and AC-TH regimen.",
  "synonyms": [
    "AC-T-T",
    "AC-T-T regimen",
    "AC-TH regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/sequential-ac-taxol-trastuzumab-regimen/"
}

Record 14,849 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.